Melanoma Central

Findings from a recent retrospective study demonstrated a multiyear decline in the population-level mortality of melanoma. This decline has been associated with the FDA approval of 10 novel treatments for metastatic melanoma since 2011.

Joshua Arbesman, MD, dermatologist and melanoma specialist at Cleveland Clinic, spoke with Healio about screening for melanoma. He highlighted those patients at the highest risk for melanoma development, the benefits and challenges of using telehealth for screening and the advantages of using advanced technology for screening and detection.